Understand the complete disease landscape and size global markets with real-world data. DRG’s Epidemiology cover 140+ diseases, 40+ countries, 3,400 patient segments, including extensive insights of oncology populations by stage, line of therapy, and biomarker. Learn more about DRG Epidemiology here.

The poster below was presented by DRG Epidemiologist Jayati Saha, PhD; Deepti Sharma BDS, MPH; Nicole Zhang MPH, Alison Isherwood PhD, at Biomarkers India on EGFR-Positive Cases Among Diagnosed Non-Small-Cell Lung Cancer Patients in the Asia Pacific Region- A 10-Year Forecast.

 

How Glympse Bio oversubscribed their Series B funding amidst the pandemic

View Now